Cargando…
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compen...
Autores principales: | Grover, Vijay P. B., McPhail, Mark J. W., Wylezinska-Arridge, Marzena, Crossey, Mary M. E., Fitzpatrick, Julie A., Southern, Louise, Saxby, Brian K., Cook, Nicola A., Cox, I. Jane, Waldman, Adam D., Dhanjal, Novraj S., Bak-Bol, Aluel, Williams, Roger, Morgan, Marsha Y., Taylor-Robinson, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225223/ https://www.ncbi.nlm.nih.gov/pubmed/27488112 http://dx.doi.org/10.1007/s11011-016-9881-3 |
Ejemplares similares
-
l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
por: Butterworth, Roger F., et al.
Publicado: (2019) -
Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging
por: Grover, V. P. B., et al.
Publicado: (2016) -
Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
por: Kircheis, Gerald, et al.
Publicado: (2019) -
Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats
por: Najmi, Abul K., et al.
Publicado: (2010) -
Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs
por: Ahn, Jin-Ok, et al.
Publicado: (2016)